IP Library Granted Patent US 8,512,968
Granted Patent B2
US 8,512,968 · App. 12/739,691 · Granted Aug 20, 2013

Methods, reagents and kits for luciferase assay

Inventor: Harry Van Lune (Aduard, NL)
Assignee: Perkinelmer Health Sciences B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,512,968
App. No.
12/739,691
Granted
Aug 20, 2013
Kind
B2
Abstract

The invention relates to methods, reagents and kits for detecting enzyme activity using bioluminescence. In particular, it relates to a novel luciferase assay system with reduced background luminescence to allow for increased detection sensitivity. Provided is a method of detecting luciferase activity in a sample using coelenterazine or an analog thereof as a substrate, comprising: (a) initiating luciferase-catalyzed luminescence production by contacting said sample with a luciferase detection reagent to yield a reaction mixture, said reagent comprising coelenterazine and at least one iodide source in an amount sufficient to reduce the autoluminescence of said coelenterazine, (b) incubating said reagent mixture under conditions suitable to produce luminescence, and (c) measuring the luminescence produced. Also provided are detections reagents and kits for use in such a method.

Claims (11)

1. A method of detecting luciferase activity in a sample using coelenterazine or an analog thereof as a substrate, comprising:

a) preparing a reaction mixture by contacting said sample with coelenterazine or an analog thereof and with at least one iodide source in an amount sufficient to reduce the autoluminescence of said coelenterazine or analog,

b) incubating said reaction mixture under conditions suitable to produce luminescence, and

c) measuring the luminescence produced.

2. The method of claim 1 , wherein said at least one iodide source is an iodide salt.

3. The method of claim 1 , wherein the coelenterazine or analog is selected from the group consisting of native coelenterazine, coelenterazine cp, coelenterazine f, coelenterazine fcp, coelenterazine h, coelenterazine hcp, coelenterazine i, coelenterazine ip and coelenterazine n.

4. The method of claim 1 , wherein the coelenterazine or analog thereof is present in the reaction mixture in a concentration of 2-5 μM.

5. The method of claim 1 , wherein said reaction mixture comprises about 0.02 mM to about 500 mM iodide.

6. The method of claim 2 wherein said iodide salt is selected from the group consisting of NaI, KI, LiI and NH 4 I, or any combination thereof.

7. The method of claim 1 wherein the reaction mixture is a 1-10 mM EDTA buffer solution having a pH between 7.2-8.0.

8. The method of claim 4 wherein the reaction mixture is a 1-10 mM EDTA buffer solution having a pH between 7.2-8.0.

Assignments (2)
CHANGE OF NAME Recorded Mar 22, 2024
From: PERKINELMER HEALTH SCIENCES B.V.
To: REVVITY HEALTH SCIENCES B.V.
Reel/Frame 066876/0858 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2011
From: VAN LUNE, HARRY
To: PERKINELMER HEALTH SCIENCES B.V.
Reel/Frame 026660/0993 →
Priority Claims (1)
EP 07150428 · Dec 27, 2007 · regional
Continuity (2)
Provisional Application 60983443 · Oct 29, 2007
Related Publication 20110256564A1 · Oct 20, 2011